GO:2001076 positive regulation of metanephric ureteric bud development: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001076 describes any biological process that activates or increases the frequency, rate, or extent of metanephric ureteric bud development.
• Ureteric bud outgrowth from the Wolffian duct is a critical early step in kidney organogenesis, and its positive regulation ensures proper branching morphogenesis and nephron formation [1,2].
• Key positive regulators include growth factors such as GDNF, FGFs, and BMPs, while inhibitors like activin A and TGF-beta superfamily members can restrict bud outgrowth [5,7].
• Dysregulation of ureteric bud development is linked to congenital anomalies of the kidney and urinary tract (CAKUT), including renal agenesis and hypoplasia.
• Genes such as Sall1, Six2, and Cd44 modulate ureteric bud cell proliferation, survival, and branching, and their misexpression can disrupt kidney development [3,6,8].
• CRISPR-based knockout, knock-in, and overexpression models are essential for dissecting the causal roles of specific genes in positive regulation of ureteric bud development [3,8].
Description
The development of the metanephric kidney depends on a series of reciprocal inductive interactions between the metanephric mesenchyme and the ureteric bud, an outgrowth of the Wolffian duct. The ureteric bud invades the metanephric mesenchyme and undergoes repeated branching to form the collecting duct system, while the surrounding mesenchyme condenses and differentiates into nephrons [1,2]. The precise spatial and temporal regulation of ureteric bud outgrowth is essential for normal kidney formation, and perturbations in this process lead to a spectrum of congenital anomalies of the kidney and urinary tract (CAKUT). GO:2001076, positive regulation of metanephric ureteric bud development, captures the set of processes that stimulate or enhance this developmental program. Research into GO:2001076 has identified multiple signaling pathways and transcription factors that promote ureteric bud induction, outgrowth, and branching. For example, glial cell line-derived neurotrophic factor (GDNF) signaling through the RET receptor tyrosine kinase is a well-established positive regulator of ureteric bud outgrowth. Other growth factors, including fibroblast growth factors (FGFs) and bone morphogenetic proteins (BMPs), also modulate ureteric bud development in a context-dependent manner. Conversely, inhibitory molecules such as activin A and TGF-beta superfamily members can restrict bud outgrowth, highlighting the balance of positive and negative signals required for proper kidney development [5,7]. Understanding the molecular and cellular mechanisms underlying positive regulation of metanephric ureteric bud development is crucial for uncovering the etiology of kidney malformations and for developing regenerative strategies. This article synthesizes current knowledge on the ontology term GO:2001076, its associated genes, regulatory mechanisms, and the experimental models used to study it, with a focus on CRISPR-based approaches for functional validation [3,8].
positive regulation of metanephric ureteric bud development At A Glance
| GO ID | GO:2001076 |
|---|---|
| GO term | positive regulation of metanephric ureteric bud development |
| Ontology | biological_process |
| Synonym | none |
| Major function | Stimulation of ureteric bud outgrowth, branching, and elongation during metanephric kidney development [1,2] |
| Related processes | Metanephric ureteric bud development, branching morphogenesis, nephron formation [1,2] |
| Key signaling pathways | GDNF/RET, FGF, BMP, TGF-beta superfamily [1,5,7] |
| Associated genes | GDNF, RET, SALL1, SIX2, CD44, and others [1,3,6,8] |
| Disease relevance | Congenital anomalies of the kidney and urinary tract (CAKUT) |
What Is GO:2001076?
GO:2001076, positive regulation of metanephric ureteric bud development, is a biological process term defined as any process that activates or increases the frequency, rate, or extent of metanephric ureteric bud development. In other words, it encompasses all molecular and cellular events that promote the initial outgrowth of the ureteric bud from the Wolffian duct and its subsequent branching within the metanephric mesenchyme during kidney organogenesis [1,2].
Why Is positive regulation of metanephric ureteric bud development Important in Cell Biology?
Positive regulation of metanephric ureteric bud development is fundamental to kidney organogenesis, as it ensures the proper initiation and branching of the ureteric bud, which ultimately determines nephron number and renal function [1,2]. Disruption of this process leads to severe congenital kidney malformations, including renal agenesis and hypoplasia, which are major causes of pediatric kidney failure. Therefore, understanding the positive regulators of ureteric bud development is critical for elucidating the pathogenesis of CAKUT and for developing targeted therapeutic interventions.
• Ureteric bud outgrowth is the first morphological sign of metanephric kidney development, and its positive regulation is essential for establishing the collecting duct system.
• Proper branching morphogenesis of the ureteric bud determines the final number of nephrons, which correlates with long-term kidney health.
• Dysregulation of positive regulators can lead to renal agenesis, hypoplasia, or dysplasia, collectively known as CAKUT.
• GDNF/RET signaling is a major positive regulatory pathway, and mutations in these genes cause renal agenesis in mice and humans.
• Sall1 and Six2 are transcription factors that modulate ureteric bud development and nephron progenitor survival [3,8].
• CD44 and hyaluronan interactions promote branching morphogenesis of ureteric bud cells in vitro.
• TGF-beta superfamily members, including BMPs, can either promote or inhibit ureteric bud growth depending on context.
• Activin A acts as an endogenous inhibitor of ureteric bud outgrowth, demonstrating the need for balanced positive and negative signals.
• Understanding positive regulation informs regenerative medicine approaches to rebuild kidney tissue.
• CRISPR screens can identify novel positive regulators of ureteric bud development, accelerating discovery [3,8].
What Happens During positive regulation of metanephric ureteric bud development?
Induction of ureteric bud outgrowth
In simple terms: The ureteric bud is told to start growing out from the Wolffian duct.
Positive regulation begins with the secretion of inductive signals from the metanephric mesenchyme, most notably GDNF, which binds to the RET receptor on the Wolffian duct epithelium and triggers ureteric bud outgrowth. This process also involves the activation of downstream signaling cascades, including the MAPK and PI3K pathways, which promote cell proliferation and migration at the bud tip [1,2].
Branching morphogenesis and elongation
In simple terms: The bud grows and splits into branches to form the collecting duct system.
Once the ureteric bud invades the metanephric mesenchyme, it undergoes repeated dichotomous branching, a process driven by localized cell proliferation and extracellular matrix remodeling. Positive regulators such as FGFs and BMPs modulate branching by influencing cell shape, adhesion, and proliferation. Hyaluronan and its receptor CD44 also promote branching morphogenesis in vitro.
Reciprocal signaling with metanephric mesenchyme
In simple terms: The bud and the surrounding tissue talk to each other to coordinate growth.
The ureteric bud secretes factors that induce the metanephric mesenchyme to condense and form nephrons, while the mesenchyme produces signals that sustain bud growth. This reciprocal induction is essential for positive regulation, as disruption of either side impairs kidney development [1,3].
Modulation by transcription factors
In simple terms: Master switches inside cells control which genes are turned on or off to promote bud growth.
Transcription factors such as Sall1 and Six2 play critical roles in regulating the expression of genes involved in ureteric bud development and nephron progenitor survival [3,8]. For example, knockdown of neurofibromin downregulates Six2 and leads to apoptosis of metanephric mesenchyme cells, highlighting the importance of transcriptional control in positive regulation.
Balance with inhibitory signals
In simple terms: There are also brakes that prevent the bud from growing too much.
Positive regulation is counterbalanced by inhibitory molecules such as activin A and certain TGF-beta superfamily members, which can restrict ureteric bud outgrowth [5,7]. The interplay between positive and negative signals ensures proper patterning and prevents excessive branching [5,7].
Key Genes Involved in GO:2001076 positive regulation of metanephric ureteric bud development
The following genes and proteins have been implicated in the positive regulation of metanephric ureteric bud development, based on published experimental evidence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GDNF | Secreted ligand that induces ureteric bud outgrowth via RET | Knockout causes renal agenesis; target for enhancing bud induction |
| RET | Receptor tyrosine kinase for GDNF; mediates positive signals | Mutations linked to CAKUT; key node in positive regulation |
| SALL1 | Transcription factor essential for kidney development | Mutations cause Townes-Brocks syndrome with renal anomalies |
| SIX2 | Transcription factor maintaining nephron progenitors | Downregulation leads to apoptosis; affects bud-mesenchyme interaction |
| CD44 | Cell surface receptor for hyaluronan; promotes branching | Modulates ureteric bud cell branching in vitro |
| BMP4 | Bone morphogenetic protein; context-dependent regulator | Can promote or inhibit bud growth depending on concentration |
| BMP7 | Bone morphogenetic protein; promotes ureteric bud growth | Knockout leads to severe kidney defects |
| FGF2 | Fibroblast growth factor; stimulates bud elongation | Enhances branching in culture models |
| FGF7 | Fibroblast growth factor; promotes ureteric bud proliferation | Used to support in vitro bud growth |
| Activin A | TGF-beta family member; endogenous inhibitor of bud outgrowth | Negative regulator; its inhibition may enhance bud growth |
| TGF-beta1 | TGF-beta superfamily member; modulates branching | Context-dependent effects on ureteric bud |
| NF1 | Neurofibromin; regulates Six2 expression and cell survival | Knockdown reduces Six2 and induces apoptosis |
| PAX2 | Transcription factor; early regulator of ureteric bud | Mutations associated with CAKUT |
| WT1 | Transcription factor; essential for metanephric mesenchyme | Mutations cause Wilms tumor and nephropathy |
| EYA1 | Transcription coactivator; involved in bud outgrowth | Mutations cause branchio-oto-renal syndrome |
| SIX1 | Transcription factor; cooperates with EYA1 | Mutations linked to CAKUT |
| GATA3 | Transcription factor; regulates ureteric bud differentiation | Mutations cause renal anomalies |
| HNF1B | Transcription factor; controls ureteric bud gene expression | Mutations associated with renal cysts and diabetes |
How Is positive regulation of metanephric ureteric bud development Regulated?
Positive regulation of metanephric ureteric bud development is controlled by a complex interplay of secreted growth factors, cell surface receptors, and intracellular signaling pathways. GDNF/RET signaling is a primary positive regulator, but its activity is modulated by other pathways such as FGF, BMP, and TGF-beta superfamily members [1,5,7]. For instance, activin A acts as an endogenous inhibitor, and its downregulation can enhance bud outgrowth. Additionally, transcription factors like Sall1 and Six2 regulate the expression of genes that promote or maintain the ureteric bud program [3,8]. The balance between positive and negative signals ensures proper kidney development, and disruption of this balance leads to congenital anomalies.
positive regulation of metanephric ureteric bud development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GDNF | Renal agenesis, CAKUT | Knockout mouse, CRISPR KO in ureteric bud cells |
| RET | CAKUT, Hirschsprung disease | Point mutation knock-in mouse, organoid culture |
| SALL1 | Townes-Brocks syndrome with renal anomalies | Knockout mouse, patient-derived iPSCs |
| SIX2 | CAKUT, nephron progenitor defects | Knockdown/knockout in metanephric mesenchyme cells |
| EYA1 | Branchio-oto-renal syndrome | Knockout mouse, CRISPR KO in zebrafish |
Congenital anomalies of the kidney and urinary tract (CAKUT)
Dysregulation of positive regulation of metanephric ureteric bud development is a major cause of CAKUT, which includes renal agenesis, hypoplasia, and dysplasia. Mutations in genes such as GDNF, RET, SALL1, and PAX2 have been linked to these conditions, highlighting the clinical importance of this process [1,3,4].
Renal agenesis and hypoplasia
Failure of ureteric bud outgrowth or branching due to loss of positive regulators leads to renal agenesis (absence of kidney) or hypoplasia (small kidney) [1,4]. Animal models with knockout of Gdnf or Ret exhibit renal agenesis, demonstrating the essential role of positive regulation.
Wilms tumor and nephroblastoma
Aberrant activation of developmental pathways, including those regulating ureteric bud development, can contribute to Wilms tumor, a pediatric kidney cancer. Mutations in WT1 and other genes involved in kidney development are associated with Wilms tumor.
Branchio-oto-renal syndrome
Mutations in EYA1, a positive regulator of ureteric bud development, cause branchio-oto-renal syndrome, characterized by kidney malformations, hearing loss, and branchial arch anomalies.
From positive regulation of metanephric ureteric bud development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote ureteric bud outgrowth? | CRISPR knockout in ureteric bud cell lines or mouse models [1,3] |
| What is the effect of a specific point mutation in RET on bud development? | Point mutation knock-in via CRISPR in mouse embryos or organoids |
| Can overexpression of GDNF enhance branching? | Transgenic overexpression or CRISPR activation in ureteric bud cells |
| How does tagging a protein affect its localization during bud development? | Knock-in of fluorescent tag (e.g., GFP) using CRISPR |
| What are the downstream targets of Sall1? | Knockout followed by RNA-seq in metanephric mesenchyme |
| Can we identify novel positive regulators via high-throughput screening? | CRISPR library screening in ureteric bud organoids [3,8] |
How to Study the positive regulation of metanephric ureteric bud development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify downstream targets of positive regulators |
| Proteomics | Protein abundance and modifications | Map signaling networks in ureteric bud |
| Live imaging | Real-time branching dynamics | Visualize effects of growth factors [2,6] |
| In vitro branching assay | Branching morphogenesis | Test positive regulators like CD44/hyaluronan |
| CRISPR knockout | Loss-of-function phenotypes | Determine if gene is required for bud development |
| CRISPR knock-in | Tagged protein localization | Track protein dynamics during bud outgrowth |
| Organoid culture | 3D kidney tissue development | Model CAKUT and test therapeutics |
| ChIP-seq | Transcription factor binding sites | Identify targets of Sall1, Six2 [3,8] |
Transcriptomics and RNA-seq
RNA sequencing can reveal gene expression changes in ureteric bud cells upon manipulation of candidate positive regulators. For example, knockdown of neurofibromin downregulates Six2, which can be detected by RNA-seq.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can identify signaling proteins and post-translational modifications downstream of GDNF/RET and other pathways that positively regulate ureteric bud development.
Imaging and lineage tracing
Live imaging of fluorescently labeled ureteric bud cells in organ culture allows real-time visualization of branching morphogenesis and the effects of positive regulators [2,6].
In vitro branching assays
Ureteric bud cells cultured in three-dimensional matrices can be stimulated with growth factors to assess branching morphogenesis, as demonstrated with hyaluronan and CD44.
How CRISPR Can Be Used to Study GO:2001076 positive regulation of metanephric ureteric bud development
Knockout
CRISPR knockout of candidate positive regulators such as Gdnf or Ret in mouse embryos or ureteric bud cell lines can confirm their essential roles in bud outgrowth and branching. For example, knockout of Sall1 leads to kidney defects, validating its function.
Point Mutation
Introducing specific point mutations in genes like RET using CRISPR can model human CAKUT-associated variants and assess their impact on ureteric bud development [1,4].
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci such as Sall1 allows visualization of protein expression and localization during ureteric bud development.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of positive regulators like GDNF can enhance ureteric bud outgrowth and branching, providing gain-of-function evidence.
How EDITGENE Supports positive regulation of metanephric ureteric bud development Research
Researchers studying positive regulation of metanephric ureteric bud development-related genes often need to determine whether a candidate gene is causally involved in promoting bud outgrowth, branching, or nephron formation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of metanephric ureteric bud development research.
Frequently Asked Questions About positive regulation of metanephric ureteric bud development
What is GO:2001076?
GO:2001076 is a Gene Ontology term for positive regulation of metanephric ureteric bud development, describing processes that increase the frequency, rate, or extent of ureteric bud outgrowth and branching during kidney development.
What genes are involved in positive regulation of metanephric ureteric bud development?
Key genes include GDNF, RET, SALL1, SIX2, CD44, BMP4, BMP7, FGF2, FGF7, and others that promote ureteric bud outgrowth and branching [1,3,6,7,8].
How does GDNF regulate ureteric bud development?
GDNF secreted by the metanephric mesenchyme binds to RET on the Wolffian duct, activating signaling pathways that stimulate ureteric bud outgrowth and branching.
What diseases are associated with defects in ureteric bud development?
Defects can cause congenital anomalies of the kidney and urinary tract (CAKUT), including renal agenesis, hypoplasia, and dysplasia.
What is the role of Sall1 in kidney development?
Sall1 is a transcription factor essential for kidney development; mutations cause Townes-Brocks syndrome with renal anomalies.
How can CRISPR be used to study positive regulation of ureteric bud development?
CRISPR knockout, knock-in, and overexpression can validate gene function in ureteric bud cells and animal models, revealing causal roles in bud outgrowth [1,3,8].
What are the signaling pathways that positively regulate ureteric bud development?
Major pathways include GDNF/RET, FGF, BMP, and TGF-beta superfamily signaling, which together promote bud outgrowth and branching [1,5,7].
What is the role of CD44 in ureteric bud branching?
CD44, a receptor for hyaluronan, promotes branching morphogenesis of ureteric bud cells in vitro.
How does activin A affect ureteric bud outgrowth?
Activin A acts as an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct, counterbalancing positive signals.
What experimental models are used to study positive regulation of metanephric ureteric bud development?
Models include mouse knockouts, organoid cultures, in vitro branching assays, and CRISPR-engineered cell lines [1,2,3,6].
Conclusion
Positive regulation of metanephric ureteric bud development (GO:2001076) is a critical biological process that ensures proper kidney formation. Through the coordinated action of growth factors, receptors, and transcription factors, it drives ureteric bud outgrowth and branching, and its dysregulation leads to congenital kidney anomalies [1,4]. Continued research using CRISPR-based models and high-throughput screening will further elucidate the molecular players and mechanisms, potentially informing new therapeutic strategies for CAKUT and kidney regeneration [3,8].
References
- 1. Sakurai H. 2003. Molecular mechanism of ureteric bud development.. Semin Cell Dev Biol 14(4):217-24 PMID: 14627120
- 2. Michael L et al.. 2004. Pattern and regulation of cell proliferation during murine ureteric bud development.. J Anat 204(4):241-55 PMID: 15061751
- 3. Nishinakamura R et al.. 2005. Essential roles of Sall1 in kidney development.. Kidney Int 68(5):1948-50 PMID: 16221172
- 4. Zwolińska D et al.. 2011. [Genetics of congenital anomalies of the kidney and urinary tract].. Postepy Hig Med Dosw (Online) 65:829-37 PMID: 22173447
- 5. Maeshima A et al.. 2006. Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct.. Dev Biol 295(2):473-85 PMID: 16643884
- 6. Pohl M et al.. 2000. Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells.. Dev Biol 224(2):312-25 PMID: 10926769
- 7. Bush KT et al.. 2004. TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud.. Dev Biol 266(2):285-98 PMID: 14738877
- 8. Zhou P et al.. 2014. Down-regulated Six2 by knockdown of neurofibromin results in apoptosis of metanephric mesenchyme cells in vitro.. Mol Cell Biochem 390(1-2):205-13 PMID: 24573885
